Ketryx
AI NativeDevelop fast. Stay compliant.
Est 2021|Valuation $112M|Raised $57M
Published Jul 14, 2026
| Starting Price | Published free plan with vendor-defined eligibility criteria | Public pricing page exists but exact entry price not captured here | “Get Your Pricing” (sales-led; no public list price) |
| Typical Fit | Devtool-centric regulated software teams (Jira/Git) seeking continuous traceability and automated documentation generation | Teams seeking a MedTech-focused QMS with regulatory templates and vendor-provided support | Broader life sciences organizations needing a mature, broad QMS suite |
| Key Strength | Toolchain integration; continuous documentation/traceability; published free tier | MedTech-specific QMS defaults and templates; regulatory support positioning | Mature platform footprint and breadth; established vendor presence |
| Key Weakness | Low public review volume; some features are under development; may not cover full QMS workflows natively | Competitor and community feedback sometimes cites cost and scope concerns | Pricing opacity and potential implementation complexity |
—
Ketryx vs Greenlight Guru (Ultralight)
Ketryx vs MasterControl